syhx1901
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
1
Phase 4
0
Earliest trial started Apr 11, 2023 (NCT05858047)
Timeline
Indications
Mechanism of action
- Tyrosine-protein kinase TYK2INHIBITOR
TYK2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06943950 | Phase 3 | Jun 1, 2025 | Yiling Pharmaceutical Inc. |
| NCT06562894 | Phase 2 | Nov 16, 2024 | Yiling Pharmaceutical Inc. |
| NCT06511739 | Phase 2 | May 27, 2024 | Yiling Pharmaceutical Inc. |
| NCT05858047 | Phase 2 | Apr 11, 2023 | Yiling Pharmaceutical Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Yiling Pharmaceutical Inc. | For profit | 4 | 4 | 2 | 2023 |
1 organizations
Page 1 / 1